These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21198547)

  • 1. Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD.
    Moulton BC; Fryer AD
    Br J Pharmacol; 2011 May; 163(1):44-52. PubMed ID: 21198547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscarinic Receptor Antagonists.
    Matera MG; Cazzola M
    Handb Exp Pharmacol; 2017; 237():41-62. PubMed ID: 27787709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of airway inflammation and remodeling by muscarinic receptors: perspectives on anticholinergic therapy in asthma and COPD.
    Kistemaker LE; Oenema TA; Meurs H; Gosens R
    Life Sci; 2012 Nov; 91(21-22):1126-33. PubMed ID: 22406302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled muscarinic acetylcholine receptor antagonists for treatment of COPD.
    Montuschi P; Macagno F; Valente S; Fuso L
    Curr Med Chem; 2013; 20(12):1464-76. PubMed ID: 22963553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscarinic receptor signaling in the pathophysiology of asthma and COPD.
    Gosens R; Zaagsma J; Meurs H; Halayko AJ
    Respir Res; 2006 May; 7(1):73. PubMed ID: 16684353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic receptor antagonists: effects on pulmonary function.
    Buels KS; Fryer AD
    Handb Exp Pharmacol; 2012; (208):317-41. PubMed ID: 22222705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Research and development of bronchodilators for asthma and COPD with a focus on G protein/KCa channel linkage and β2-adrenergic intrinsic efficacy.
    Kume H; Fukunaga K; Oguma T
    Pharmacol Ther; 2015 Dec; 156():75-89. PubMed ID: 26432616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticholinergics/antimuscarinic drugs in asthma.
    Soler X; Ramsdell J
    Curr Allergy Asthma Rep; 2014 Dec; 14(12):484. PubMed ID: 25283149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology and therapeutics of bronchodilators.
    Cazzola M; Page CP; Calzetta L; Matera MG
    Pharmacol Rev; 2012 Jul; 64(3):450-504. PubMed ID: 22611179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of bronchial tone in chronic obstructive pulmonary disease (COPD): role of muscarinic receptors].
    Abad Santos F; Novalbos J; Gallego Sandín S; Gálvez Múgica MA
    An Med Interna; 2003 Apr; 20(4):201-5. PubMed ID: 12768836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscarinic antagonists in early stage clinical development for the treatment of asthma.
    Albertson TE; Chenoweth JA; Adams JY; Sutter ME
    Expert Opin Investig Drugs; 2017 Jan; 26(1):35-49. PubMed ID: 27927039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new perspective on muscarinic receptor antagonism in obstructive airways diseases.
    Meurs H; Oenema TA; Kistemaker LE; Gosens R
    Curr Opin Pharmacol; 2013 Jun; 13(3):316-23. PubMed ID: 23643733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of a novel class of inhaled dual pharmacology muscarinic antagonist and β
    Rancati F; Linney ID; Rizzi A; Delcanale M; Knight CK; Schmidt W; Pastore F; Riccardi B; Mileo V; Carnini C; Cesari N; Blackaby WP; Patacchini R; Carzaniga L
    Bioorg Med Chem Lett; 2021 Jun; 41():127975. PubMed ID: 33753262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The non-neuronal cholinergic system as novel drug target in the airways.
    Pieper MP
    Life Sci; 2012 Nov; 91(21-22):1113-8. PubMed ID: 22982180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscarinic antagonist-beta-adrenergic agonist dual pharmacology molecules as bronchodilators: a patent review.
    Ray NC; Alcaraz L
    Expert Opin Ther Pat; 2009 Jan; 19(1):1-12. PubMed ID: 19441894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding modes and pharmacophoric features of muscarinic antagonism and β2 agonism (MABA) conjugates.
    Bandaru S; Prasad MH; Jyothy A; Nayarisseri A; Yadav M
    Curr Top Med Chem; 2013; 13(14):1650-5. PubMed ID: 23889054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptors and their antagonists in COPD: anti-inflammatory and antiremodeling effects.
    Karakiulakis G; Roth M
    Mediators Inflamm; 2012; 2012():409580. PubMed ID: 23226927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Asthma and COPD: guidance in the jungle of inhalative drugs].
    Hering T
    MMW Fortschr Med; 2015 May; 157(10):59, 61-2. PubMed ID: 26019099
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-acting muscarinic receptor antagonists for the treatment of respiratory disease.
    Cazzola M; Page C; Matera MG
    Pulm Pharmacol Ther; 2013 Jun; 26(3):307-17. PubMed ID: 23274274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revefenacin for the treatment of chronic obstructive pulmonary disease.
    Li F; Yang J
    Expert Rev Clin Pharmacol; 2019 Apr; 12(4):293-298. PubMed ID: 30803279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.